Jianfeng Group announced that Anhui Jianfeng North Carolina Pharmaceutical Co., Ltd., a subsidiary of the company, has received the European Pharmacopeia applicability certification for methyldopa APIs issued by the European Medicines Quality Administration. The certificate will take effect from September 22, 2026. The product has previously been approved for the marketing of domestic chemical raw materials. Obtaining the CEP certificate indicates that it has the qualifications to enter the European Union and other markets that recognize CEP certificates in the form of APIs, which has had a positive impact on the company's expansion into the international market. The international API business is susceptible to factors such as the overseas market environment and exchange rate fluctuations, and there is uncertainty.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.